Literature DB >> 24977015

Surgery for giant emphysematous bullae: case report and a short literature review.

Wenting Huang1, Rui Han1, Li Li1, Yong He1.   

Abstract

Giant bullous emphysema (GBE), known as 'vanishing lung syndrome', usually occurs in association with chronic obstructive pulmonary disease (COPD). In this report, we describe a patient with giant emphysematous bulla occupying approximately 95% of the right hemithorax, who had history of repeated attacks of acute exacerbation of COPD. About 95% of right pulmonary parenchyma was removed. Delightfully, the 5% of residual lung compressed for 4 years gradually inflated, and occupied the whole hemithorax. Preoperatively he was functionally and clinically severely disabled while improved markedly after bullectomy.

Entities:  

Keywords:  Giant pulmonary bulla; lung function; preoperative evaluation; video-assisted thoracoscopic surgery

Year:  2014        PMID: 24977015      PMCID: PMC4073409          DOI: 10.3978/j.issn.2072-1439.2014.04.39

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  Giant bullous emphysema resection by VATS. Analysis of laser and stapler techniques.

Authors:  Duilio Divisi; Carmelo Battaglia; William Di Francescantonio; Guido Torresini; Roberto Crisci
Journal:  Eur J Cardiothorac Surg       Date:  2002-12       Impact factor: 4.191

2.  Spontaneous resolution of a giant pulmonary bulla in an older woman: role of functional assessment.

Authors:  Simone Scarlata; Matteo Cesari; Irene Caridi; Domenica Chiurco; Raffaele Antonelli-Incalzi
Journal:  Respiration       Date:  2010-06-26       Impact factor: 3.580

3.  An alternative technique in the management of bullous emphysema. Thoracoscopic endoloop ligation of bullae.

Authors:  H P Liu; C H Chang; P J Lin; J J Chu; M J Hsieh
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

4.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

5.  Non-surgical management of giant lung bullae during mechanical ventilation.

Authors:  Sheng-Yuan Ruan; Chun-Ta Huang; Jung-Yien Chien; Yao-Wen Kuo; Chong-Jen Yu
Journal:  Respir Care       Date:  2011-04-19       Impact factor: 2.258

6.  The surgical management of bullous emphysema.

Authors:  J Gunstensen; R J McCormack
Journal:  J Thorac Cardiovasc Surg       Date:  1973-06       Impact factor: 5.209

7.  Surgical treatment of bullous lung disease.

Authors:  P D Potgieter; S R Benatar; R P Hewitson; A D Ferguson
Journal:  Thorax       Date:  1981-12       Impact factor: 9.139

8.  Incidence and outcomes of surgical resection for giant pulmonary bullae--a population-based study.

Authors:  S I Gunnarsson; K B Johannesson; M Gudjonsdottir; B Magnusson; S Jonsson; T Gudbjartsson
Journal:  Scand J Surg       Date:  2012       Impact factor: 2.360

9.  Surgical treatment of bullous emphysema: experience with the Brompton technique.

Authors:  S S Shah; P Goldstraw
Journal:  Ann Thorac Surg       Date:  1994-11       Impact factor: 4.330

10.  Bullectomy for giant bullae in emphysema.

Authors:  C D Laros; H J Gelissen; P G Bergstein; J M Van den Bosch; R G Vanderschueren; C J Westermann; P J Knaepen
Journal:  J Thorac Cardiovasc Surg       Date:  1986-01       Impact factor: 5.209

View more
  3 in total

1.  Concomitant a giant pulmonary bulla on the left lower lobe and hamartoma successfully treated by video-assisted thoracoscopic pulmonary wedge resection.

Authors:  Jun An; Meijun Long; Ye Jiang; Yi Jin
Journal:  AME Case Rep       Date:  2017-09-26

2.  A breath from Houdini - A case of giant bullous emphysema.

Authors:  Chee Kiang Tay; Yuen Li Ng
Journal:  Respir Med Case Rep       Date:  2014-12-18

3.  Robot-assisted thoracoscopic lobectomy as treatment of a giant bulla.

Authors:  Rosa Roemers; Kornelis Patberg; Caroline van de Wauwer; Tam Nguyen; Ghada Shahin
Journal:  J Cardiothorac Surg       Date:  2017-05-18       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.